Clinical trial supply chains are built for stability, but permanent disruption is breaking RTSM assumptions and forcing a redesign of planning, inventory, and logistics architecture.
- How Clinical Supply Drives Resilience In Global Vaccine Networks
- From Inconsistency To Structure: A Model For Defensible Compliance Decisions
- Building Resilient Clinical Supply Chains To Keep Trials On Track
- Randomization And Trial Supply Management (RTSM) Systems: Meet Your Neighbor Again
- Real-World Data Is Reshaping How We Supply Clinical Trials — And It's About Time
- Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
- Designing CNS Trial Supply Chains: A Technical Framework
- Primary Healthcare Disruption And Clinical Trial Supply Risk
ON-DEMAND WEBINARS
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
Discover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.
In this interactive discussion, IQVIA Technologies' IRT experts delve into real-world examples and practical AI applications.
Guido D’Agostino, Head of Global Procurement at Chiesi, and Stefan Dürr, Senior Director of Product Management and Client Delivery at IQVIA IRT, delve into their achievements in sustainability.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![GettyImages-1254705026 clinical supplies]( "Overcoming The Challenges Of Fragmented Supply Chains")
Overcoming The Challenges Of Fragmented Supply ChainsAs trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.
-
Addressing Rare Disease Drug Product Manufacturing Challenges
Handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
-
![Vaccine Manufacturing GettyImages-1384850913]( "GxP Inventory Enhances Supply Chain For Global Specialty Biotech Firm")
GxP Inventory Enhances Supply Chain For Global Specialty Biotech FirmDiscover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.
-
![2026 start button-GettyImages-2232020388]( "How Life Sciences Leaders Are Preparing For More Curveballs In 2026")
How Life Sciences Leaders Are Preparing For More Curveballs In 2026Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
![GettyImages-2189597043-production-facility-laptop-software]( "Why RTSM Software Doesn't Belong Inside An All-In-One Suite")
Why RTSM Software Doesn't Belong Inside An All-In-One SuiteDon’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.
-
![GettyImages-2189597043-production-facility-laptop-software]( "How A Rare Disease Biotech Replaced Manual Processes With RTSM Software")
How A Rare Disease Biotech Replaced Manual Processes With RTSM SoftwareDiscover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
![Vaccine injectable vials and syringe GettyImages-1252804942]( "Developing Injectable Drug Placebo Formulations For Clinical Trials")
Developing Injectable Drug Placebo Formulations For Clinical TrialsDeveloping a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Powering Complex Personalized Medicine Oncology Trial")
Powering Complex Personalized Medicine Oncology TrialManaging custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Five Key Trends In CMC")
Five Key Trends In CMCCMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
